{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:56:49Z","timestamp":1768881409163,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,8]]},"DOI":"10.7759\/cureus.78732","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T14:13:36Z","timestamp":1739024016000},"source":"Crossref","is-referenced-by-count":1,"title":["A Retrospective Study of 10 Cases of Laparoscopic and Laparotomic Risk-Reducing Salpingo-Oophorectomy Performed on Patients With BRCA-Positive Breast Cancer"],"prefix":"10.7759","author":[{"given":"Hiroaki","family":"Ishida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Manrai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Egashira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouta","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Latest cancer statistics (Website in Japanese). (2024). https.\/\/ganjoho.jp\/reg_stat\/statistics\/stat\/summary.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou A","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, et al.. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003, 72:1117-30. 10.1086\/375033","journal-title":"Am J Hum Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj465","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada","volume":"98","author":"Risch HA","year":"2006","unstructured":"Risch HA, McLaughlin JR, Cole DE, et al.. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst. 2006, 98:1694-706. 10.1093\/jnci\/djj465","journal-title":"J Natl Cancer Inst"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"30","author":"Alsop K","year":"2012","unstructured":"Alsop K, Fereday S, Meldrum C, et al.. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol. 2012, 30:2654-63. 10.1200\/JCO.2011.39.8545","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek SM","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF, et al.. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010, 304:967-75. 10.1001\/jama.2010.1237","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck TR","year":"2009","unstructured":"Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst. 2009, 101:80-7. 10.1093\/jnci\/djn442","journal-title":"J Natl Cancer Inst"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-014-0150-5","article-title":"Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers","volume":"14","author":"Marchetti C","year":"2014","unstructured":"Marchetti C, De Felice F, Palaia I, et al.. Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers. BMC Womens Health. 2014, 14:150. 10.1186\/s12905-014-0150-5","journal-title":"BMC Womens Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004751.pub3","article-title":"Laparoscopy versus laparotomy for benign ovarian tumour","author":"Medeiros LR","year":"2009","unstructured":"Medeiros LR, Rosa DD, Bozzetti MC, et al.. Laparoscopy versus laparotomy for benign ovarian tumour. Cochrane Database Syst Rev. 2009, CD004751. 10.1002\/14651858.CD004751.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.0017","article-title":"NCCN Guidelines insights: Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020","volume":"18","author":"Daly MB","year":"2020","unstructured":"Daly MB, Pilarski R, Yurgelun MB, et al.. NCCN Guidelines insights: Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020. J Natl Compr Canc Netw. 2020, 18:380-91. 10.6004\/jnccn.2020.0017","journal-title":"J Natl Compr Canc Netw"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02016","article-title":"Risk of peritoneal carcinomatosis after risk-reducing salpingo-oophorectomy: a systematic review and individual patient data meta-analysis","volume":"40","author":"Steenbeek MP","year":"2022","unstructured":"Steenbeek MP, van Bommel MH, Bulten J, et al.. Risk of peritoneal carcinomatosis after risk-reducing salpingo-oophorectomy: a systematic review and individual patient data meta-analysis. J Clin Oncol. 2022, 40:1879-91. 10.1200\/JCO.21.02016","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0007","article-title":"Ovarian cancer, version 2.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Armstrong DK","year":"2021","unstructured":"Armstrong DK, Alvarez RD, Bakkum-Gamez JN, et al.. Ovarian cancer, version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021, 19:191-226. 10.6004\/jnccn.2021.0007","journal-title":"J Natl Compr Canc Netw"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.212","article-title":"M\u00fcllerian precursor lesions in serous ovarian cancer patients: using the SEE-Fim and SEE-End protocol","volume":"27","author":"Mingels MJ","year":"2014","unstructured":"Mingels MJ, van Ham MA, de Kievit IM, Snijders MP, van Tilborg AA, Bulten J, Massuger LF. M\u00fcllerian precursor lesions in serous ovarian cancer patients: using the SEE-Fim and SEE-End protocol. Mod Pathol. 2014, 27:1002-13. 10.1038\/modpathol.2013.212","journal-title":"Mod Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10397-009-0500-8","article-title":"Direct optical entry through Palmer\u2019s point: a new technique for those at risk of entry-related trauma at laparoscopy","volume":"7","author":"Aust TR","year":"2010","unstructured":"Aust TR, Kayani SI, Rowlands DJ. Direct optical entry through Palmer\u2019s point: a new technique for those at risk of entry-related trauma at laparoscopy. Gynecol Surg. 2010, 7:315-7. 10.1007\/s10397-009-0500-8","journal-title":"Gynecol Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan MJ","year":"2007","unstructured":"Callahan MJ, Crum CP, Medeiros F, et al.. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007, 25:3985-90. 10.1200\/JCO.2007.12.2622","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-021-03244-w","article-title":"Recommendations for diagnosing STIC: a systematic review and meta-analysis","volume":"480","author":"Bogaerts JM","year":"2022","unstructured":"Bogaerts JM, Steenbeek MP, van Bommel MH, Bulten J, van der Laak JA, de Hullu JA, Simons M. Recommendations for diagnosing STIC: a systematic review and meta-analysis. Virchows Arch. 2022, 480:725-37. 10.1007\/s00428-021-03244-w","journal-title":"Virchows Arch"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0039","article-title":"NCCN Guidelines insights: ovarian cancer, version 1.2019","volume":"17","author":"Armstrong DK","year":"2019","unstructured":"Armstrong DK, Alvarez RD, Bakkum-Gamez JN, et al.. NCCN Guidelines insights: ovarian cancer, version 1.2019. J Natl Compr Canc Netw. 2019, 17:896-909. 10.6004\/jnccn.2019.0039","journal-title":"J Natl Compr Canc Netw"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.004","article-title":"Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline","volume":"34","author":"Sessa C","year":"2023","unstructured":"Sessa C, Balma\u00f1a J, Bober SL, et al.. Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline. Ann Oncol. 2023, 34:33-47. 10.1016\/j.annonc.2022.10.004","journal-title":"Ann Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17511","article-title":"Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: scoping review and international consensus recommendations","volume":"130","author":"Nebgen DR","year":"2023","unstructured":"Nebgen DR, Domchek SM, Kotsopoulos J, et al.. Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: scoping review and international consensus recommendations. BJOG. 2023, 130:1437-50. 10.1111\/1471-0528.17511","journal-title":"BJOG"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-010-1779-4","article-title":"Effects of three Kampo formulae: Tokishakuyakusan (TJ-23), Kamishoyosan (TJ-24), and Keishibukuryogan (TJ-25) on Japanese peri- and postmenopausal women with sleep disturbances","volume":"284","author":"Terauchi M","year":"2011","unstructured":"Terauchi M, Hiramitsu S, Akiyoshi M, et al.. Effects of three Kampo formulae: Tokishakuyakusan (TJ-23), Kamishoyosan (TJ-24), and Keishibukuryogan (TJ-25) on Japanese peri- and postmenopausal women with sleep disturbances. Arch Gynecol Obstet. 2011, 284:913-21. 10.1007\/s00404-010-1779-4","journal-title":"Arch Gynecol Obstet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e3182410159","article-title":"Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Taku K","year":"2012","unstructured":"Taku K, Melby MK, Kronenberg F, Kurzer MS, Messina M. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials. Menopause. 2012, 19:776-90. 10.1097\/gme.0b013e3182410159","journal-title":"Menopause"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/329923-a-retrospective-study-of-10-cases-of-laparoscopic-and-laparotomic-risk-reducing-salpingo-oophorectomy-performed-on-patients-with-brca-positive-breast-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T14:13:37Z","timestamp":1739024017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/329923-a-retrospective-study-of-10-cases-of-laparoscopic-and-laparotomic-risk-reducing-salpingo-oophorectomy-performed-on-patients-with-brca-positive-breast-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.78732","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,8]]}}}